3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
2
Thrombocytosis
1
Thrombocythemia, Essential
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lung Neoplasms
1
Leukemia, Prolymphocytic, B-Cell
1
Leukemia, Neutrophilic, Chronic
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hypereosinophilic Syndrome
1
Cholangiocarcinoma
1
Carcinoma, Hepatocellular
1
Interventions
pembrolizumab
65
Nivolumab
56
Ipilimumab
34
Specimen Handling
23
Magnetic Resonance Spectroscopy
21
Cyclophosphamide
17
Biopsy
13
Radiosurgery
12
relatlimab
11
fludarabine
11
binimetinib
11
Opdualag
11
CTLA-4 Antigen
11
trametinib
10
fludarabine phosphate
8
dabrafenib
8
lifileucel
7
encorafenib
7
aldesleukin
7
atezolizumab
6
Interleukin-2
6
cemiplimab
5
X-Rays
5
Paclitaxel
5
Immunoglobulin G
5
Blood Specimen Collection
5
Taxes
4
Radiotherapy
4
Pemetrexed
4
Gemcitabine
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Melanoma
×
pevonedistat
×
90 days
×
Clear all
No trials found.